Search Results

• • 1,935 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Abstracts from global literature: outcomes of human papilloma virus infection in pregnancy and in newborns

  Author:Sonia JainFrom:Indian Journal of Sexually Transmitted Diseases and AIDS (Vol. 34, Issue 2) Peer-Reviewed

  July-December 20132,025 words Author abstract 1190LByline: Sonia. Jain Photodynamic therapy of condyloma acuminata in pregnant women Yang YG, Zou XB, Zhao H, Zhang YJ, Li HJ. Chin Med J (Engl) 2012;125:2925-8. Background: Condyloma acuminatum (CA) is a highly...

• Antiretrovirals: immune reconstitution disease and human papillomavirus infection

  From:Reactions Weekly (Issue 1341)

  Mar. 5, 2011260 words Brief article, Case ... 1290LAn event is serious (FDA MedWatch definition) when the patient outcome is: death death life-threatening hospitalisation disability congenital anomaly requires intervention to prevent permanent...

• Young adult learning about human papillomavirus on the internet: what are the common misconceptions?

  Authors:Jonathan Hilpert, Melissa Carrion, Sarah K. Brem, Maria Ciani, and Keith CianiFrom:American Journal of Health Studies (Vol. 25, Issue 1) Peer-Reviewed

  Winter 20105,852 words Article 1410LThe purpose of this study was to examine young adult learning about Human Papillomavirus (HPV) during a realistic internet search. The results indicated that before the search there were widespread misconceptions about...

• Monitoring the coverage and impact of human papillomavirus vaccine--report of WHO meeting, November 2009/Surveillance de la couverture et des effets du vaccin antipapillomavirus humain--rapport d'une reunion de l'OMS, novembre 2009

  From:Weekly Epidemiological Record (Vol. 85, Issue 25)

  June 18, 20106,634 words Report 1850LWHO recommends that routine vaccination against human papillomavirus (HPV) be included in national immunization programmes provided that (i) the prevention of cervical cancer or other HPV-related diseases constitutes a...

• Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions

  Authors:Luciane Noal Calil, Cristine Nascente Igansi, Luise Meurer, Maria Isabel Albano Edelweiss, and Mary Clarisse BozzettiFrom:The Brazilian Journal of Infectious Diseases (Vol. 15, Issue 2) Peer-Reviewed

  March-April 20113,403 words Article 1410LThe objective of this study was to identify the frequency of coinfection by human papillomavirus (HPV) and Chlamydia trachomatis (CT) in cervical lesions and relate it with immunohistochemical expression of p16INK4a and...

• Prevalence of human papillomavirus infection in women attending a gynecology/oncology clinic in Qatar

  Authors:Asma AJ Al-Thani, Aesha I Abu-Rub, Afaf Al-Ansari, Mandy Abushama, Moza Al-Khanji, and Sabah Al-LawatiFrom:Future Virology (Vol. 5, Issue 4)

  July 20103,824 words Clinical report Author(s): Asma AJ Al-Thani [[dagger]] 4 , Aesha I Abu-Rub 1 , Afaf Al-Ansari 2 , Mandy Abushama 2 , Moza Al-Khanji 1 , Sabah Al-Lawati 3 Keywords: Keywords * cervical cancer; HPV; HPV; genotypes; Qatar...

• Prophylactic HPV vaccines: the Finnish perspective

  Author:Kari J SyrjanenFrom:Expert Review of Vaccines (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 201011,144 words Clinical report 1610LAuthor(s): Kari J Syrjänen 1 Keywords : Cervarix[trademark]; cervical cancer; cost-effectiveness; efficacy; Finland; Gardasil® ; HPV disease burden; HPV vaccines; implementation; national program; organized...

• The mechanisms behind human papillomavirus-associated cancer: the role of PDZ recognition in malignant progression

  Authors:Kazunori Nagasaka, Shunsuke Nakagawa, Tetsu Yano, Yuji Taketani, and Lawrence BanksFrom:Future Virology (Vol. 6, Issue 6)

  June 20112,402 words Editorial 1420LAuthor(s): Kazunori Nagasaka 1 2 , Shunsuke Nakagawa 2 , Tetsu Yano 2 , Yuji Taketani 2 , Lawrence Banks [[dagger]â ] 3 Keywords *⪠cancer; cell polarity; E6; HPV; PDZ; PKA Cervical cancer is the second...

• Perspectives for the development of human papillomavirus vaccines and immunotherapy

  Authors:Luis G Bermudez-Humaran and Philippe LangellaFrom:Expert Review of Vaccines (Vol. 9, Issue 1) Peer-Reviewed

  Jan. 20107,609 words Report 1530LAuthor(s): Luis G Bermúdez-Humarán [[dagger]] 1 , Philippe Langella 2 Keywords : bacterial vectors; cervical cancer; human papillomavirus; immunotherapy; mucosal vaccines Cervical cancer (CxCa) remains a...

• Cervical cancer vaccine proves highly effective in recently published landmark study

  From:Oncology (Vol. 23, Issue 10) Peer-Reviewed

  Sept. 2009379 words Brief article, Clini... 1630LThe final analysis of the largest efficacy trial of a cervical cancer vaccine was published July 25, 2009, in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline's Cervarix is highly effective at...

• Test group biases and ethical concerns mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India

  Authors:R. Austin and Chengquan ZhaoFrom:CytoJournal (Vol. 6) Peer-Reviewed

  January-December 20092,331 words Viewpoint essay Byline: R. Austin, Chengquan. Zhao The study conclusions, released from prepublication embargo by the New England Journal of Medicine (NEJM ) at 5:00 PM on April 1, 2009, were dramatic. "In a low resource setting, a...

• Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts

  Authors:Vikrant V Sahasrabuddhe, Patricia Luhn, and Nicolas WentzensenFrom:Future Microbiology (Vol. 6, Issue 9)

  Sept. 201111,234 words Article 1590LAuthor(s): Vikrant V Sahasrabuddhe 1 , Patricia Luhn 1 , Nicolas Wentzensen [[dagger]] 2 Keywords * accuracy; biomarkers; cervical cancer; HPV; prevention; risk prediction; screening Cervical cancer:...

• Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium

  Authors:Lieven Annemans, Vanessa Remy, James Oyee, and Nathalie LargeronFrom:PharmacoEconomics (Vol. 27, Issue 3) Peer-Reviewed

  Mar. 20096,899 words Article Background: The introduction of a quadrivalent human papillomavirus (HPV; types 6, 11, 16, 18) vaccine is expected to significantly reduce the burden of cervical cancer, cervical intraepithelial neoplasia (CIN), genital...

• Smoking may raise women's risk of HPV

  Author:Jared RosenbergFrom:International Family Planning Perspectives (Vol. 34, Issue 3) Peer-Reviewed

  Sept. 2008275 words Author abstract, Bri... 1600LWomen who smoke cigarettes may have an increased risk of human papillomavirus (HPV) infection, according to an analysis of HPV Prevalence Survey data from 10,577 women aged 15 years or older from nine countries around...

• Human papillomavirus vaccines WHO position paper/Vaccins anti-papillomavirus humain Note d'information de l'OMS

  From:Weekly Epidemiological Record (Vol. 84, Issue 15)

  Apr. 10, 200913,035 words Report 1880LIn accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and vaccine combinations against diseases that have an...

• A sexual health prevention priority

  Authors:Stephen Peckham and Alison HannFrom:Bulletin of the World Health Organization (Vol. 86, Issue 6) Peer-Reviewed

  June 2008972 words Clinical report 1720LWittet and Tsu are right to point to the link between cervical cancer deaths and achieving the MDGs and the inequity in the burden of cervical cancer between developed and developing countries. Any programme that...

• Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix[TM]]: profile report

  Authors:Susan J. Keam and Diane M. HarperFrom:BioDrugs (Vol. 22, Issue 3) Peer-Reviewed

  May-June 20082,953 words Article 3250LWorldwide, cervical cancer is the second most common cancer in women after breast cancer. [2,3] Current statistical analyses estimate that in 2002, 493 000 new cases of invasive cervical cancer were diagnosed and that...

• Long-term follow-up of a quadrivalent HPV vaccine

  Author:John S LambertFrom:Expert Review of Vaccines (Vol. 6, Issue 2) Peer-Reviewed

  Apr. 20073,334 words Article Author(s): John S Lambert 1 Keywords: cervical cancer prevention; human papillomavirus; prevention of genital warts; vaccine Human papillomavirus (HPV) vaccines have now been licensed for use and long-term...

• For human papillomavirus (HPV)

  From:Bulletin of the World Health Organization (Vol. 85, Issue 2) Peer-Reviewed

  Feb. 200733 words Brief article 1700LWHO and the United Nations Population Fund welcomed two new vaccines for human papillomavirus (HPV), the virus that causes most cervical cancer, as a major opportunity for the developing world on 12 December....

• Human papillomavirus (HPV) and cervical cancer--the facts

  From:Primary Health Care (Vol. 16, Issue 9)

  Nov. 20062,112 words Disease/Disorder ove... 1680LIntroduction Worldwide, after breast cancer, cervical cancer is the second most common cancer that affects women. In 99.7% of all cases, cervical cancer results from a history of persistent infection by a 'high risk'...